APA (7th ed.) Citation

Chen, J., Sun, S., Li, H., Cai, X., & Wan, C. (2024). IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis. Frontiers in Immunology, 15, . https://doi.org/10.3389/fimmu.2024.1373321

Chicago Style (17th ed.) Citation

Chen, Junzhang, Shiran Sun, Hui Li, Xiong Cai, and Chidan Wan. "IL-22 Signaling Promotes Sorafenib Resistance in Hepatocellular Carcinoma via STAT3/CD155 Signaling Axis." Frontiers in Immunology 15 (2024). https://doi.org/10.3389/fimmu.2024.1373321.

MLA (9th ed.) Citation

Chen, Junzhang, et al. "IL-22 Signaling Promotes Sorafenib Resistance in Hepatocellular Carcinoma via STAT3/CD155 Signaling Axis." Frontiers in Immunology, vol. 15, 2024, https://doi.org/10.3389/fimmu.2024.1373321.